1. Home
  2. SCYX vs YQ Comparison

SCYX vs YQ Comparison

Compare SCYX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • YQ
  • Stock Information
  • Founded
  • SCYX 1999
  • YQ 2012
  • Country
  • SCYX United States
  • YQ China
  • Employees
  • SCYX N/A
  • YQ N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • SCYX Health Care
  • YQ Real Estate
  • Exchange
  • SCYX Nasdaq
  • YQ Nasdaq
  • Market Cap
  • SCYX 32.3M
  • YQ 36.7M
  • IPO Year
  • SCYX 2014
  • YQ 2020
  • Fundamental
  • Price
  • SCYX $0.75
  • YQ $5.50
  • Analyst Decision
  • SCYX
  • YQ
  • Analyst Count
  • SCYX 0
  • YQ 0
  • Target Price
  • SCYX N/A
  • YQ N/A
  • AVG Volume (30 Days)
  • SCYX 665.7K
  • YQ 47.9K
  • Earning Date
  • SCYX 11-05-2025
  • YQ 09-03-2025
  • Dividend Yield
  • SCYX N/A
  • YQ N/A
  • EPS Growth
  • SCYX N/A
  • YQ N/A
  • EPS
  • SCYX N/A
  • YQ N/A
  • Revenue
  • SCYX $3,257,000.00
  • YQ $20,003,071.00
  • Revenue This Year
  • SCYX $20.23
  • YQ N/A
  • Revenue Next Year
  • SCYX $933.90
  • YQ N/A
  • P/E Ratio
  • SCYX N/A
  • YQ N/A
  • Revenue Growth
  • SCYX N/A
  • YQ N/A
  • 52 Week Low
  • SCYX $0.66
  • YQ $1.26
  • 52 Week High
  • SCYX $1.62
  • YQ $6.31
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 37.17
  • YQ 67.58
  • Support Level
  • SCYX $0.73
  • YQ $3.90
  • Resistance Level
  • SCYX $0.91
  • YQ $6.31
  • Average True Range (ATR)
  • SCYX 0.07
  • YQ 0.52
  • MACD
  • SCYX -0.01
  • YQ 0.05
  • Stochastic Oscillator
  • SCYX 13.77
  • YQ 70.21

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

Share on Social Networks: